Clinical development of imatinib: an anticancer drug

BACKGROUND: A novel and accurate high-throughput tandem mass spectroscopic method has been developed and validated for determination of imatinib, a protein-tyrosine kinase inhibitor against chronic myeloid leukemia. MATERIALS & METHODS: Chromatographic separation was carried on XTerra(®) RP18 co...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Future Sci OA
Main Authors: Goswami, Dipanjan, Gurule, Sanjay, Lahiry, Abhiroop, Anand, Amit, Khuroo, Arshad, Monif, Tausif
Format: Artigo
Jezik:Inglês
Izdano: Future Science Ltd 2016
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5137965/
https://ncbi.nlm.nih.gov/pubmed/28031942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fso.15.92
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki